avutometinib

Drug identity checked against registry records

Also recorded as avutometinib (VS-6766)

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerNCT06072781VSTMPhase 3Recruiting2028-10-15Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.